NCT05670847: Exogenous Ketone Esters for Drug Resistant Epilepsy
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 60 planned
- Started
- 10 Jan 2023
- Primary completion
- 30 Jun 2025
- Arms
- Study group
- Results
- None posted
- 4 Jan 2023: Trial registered
- 10 Jan 2023: Trial started